anonymous
Guest
anonymous
Guest
The clearest takeaway from the recent restructuring is that NNI does NOT value the relationship between sales people and prescribers.
Relationships that were developed over years and years of calling on the same prescribers - were completely disregarded in this restructuring. Endo reps were pushed down to DCS roles. H reps were pushed everywhere. And DCS reps had their territories completely redrawn with no regard whatsoever to long-term successful relationships with prescribers.
There are always going to be issues when territory lines are re-drawn, we are used to that - it is part of pharmaceutical life. This restructuring was much more than that. Taking an Endo rep who has never called on the primary care physicians in the territory - and throwing that person into a territory where they have ZERO established relationships....all while still having an Endo position in the territory is completely ludicrous. If the Endo rep was successful (ours sure was) - leave them where they are! If they are not, this was the opportunity to let them go and start over. Instead what happened was just a reshuffling. Almost everyone is still here, just in new positions, with established relationships abandoned all across the country.
It looks like we are attempting to sabotage ourselves. Or, we are just unbelievably stupid. I cannot believe the leadership team is unbelievably stupid....I think the clearer and most obvious answer is they just see absolutely no value in established relationships with our prescribers. Which mean we are not very valuable to these people.
Relationships that were developed over years and years of calling on the same prescribers - were completely disregarded in this restructuring. Endo reps were pushed down to DCS roles. H reps were pushed everywhere. And DCS reps had their territories completely redrawn with no regard whatsoever to long-term successful relationships with prescribers.
There are always going to be issues when territory lines are re-drawn, we are used to that - it is part of pharmaceutical life. This restructuring was much more than that. Taking an Endo rep who has never called on the primary care physicians in the territory - and throwing that person into a territory where they have ZERO established relationships....all while still having an Endo position in the territory is completely ludicrous. If the Endo rep was successful (ours sure was) - leave them where they are! If they are not, this was the opportunity to let them go and start over. Instead what happened was just a reshuffling. Almost everyone is still here, just in new positions, with established relationships abandoned all across the country.
It looks like we are attempting to sabotage ourselves. Or, we are just unbelievably stupid. I cannot believe the leadership team is unbelievably stupid....I think the clearer and most obvious answer is they just see absolutely no value in established relationships with our prescribers. Which mean we are not very valuable to these people.